{"retracted":false,"update":{"timestamp":1397347200000,"doi":"10.1007/s12020-014-0240-z","type":"correction"},"doi":"10.1007/s12020-014-0179-0","journal":"Endocrine","publisher":"Springer Nature","title":"Erratum to: Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature"}
